Vaccines will be in short supply when developed. Here’s a way to prioritize who gets one

gettyimages
A weighted lottery would determine who gets a COVID-19 vaccine first. Credit: Frederic J. Brown/AFP/Getty Images

A preliminary plan devised by the Centers for Disease Control and Prevention this spring gives priority to health care workers, then to people with underlying medical conditions and older people. The C.D.C. has not yet decided whether the next in line should be Blacks and Latinos, groups disproportionately affected by the coronavirus.

But let’s suppose that health care workers and people with underlying medical conditions use up the first doses of the available vaccine. Should some be held in reserve for Black and Latino people? What about bus drivers and train conductors?

…

One solution that is starting to attract the attention of public health experts is a so-called weighted lottery, which gives everyone a chance at access, although some get a better shot than others.

Doctors and ethicists rank patients, deciding which groups should be given preference and how much. First-responders, for example, may be weighted more heavily than, say, very sick patients who are unlikely to recover.

The goal is to prevent haphazard or inequitable distribution of a treatment or vaccine when there isn’t enough to go around.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

Weighted lotteries can allow researchers to find out, in a rigorous way, which subgroups of patients do best with a new drug or vaccine. That is because allocation within a group is random. The distribution is, in effect, a randomized, controlled clinical trial.

Read the original post

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
AI Doctor with a Digital Neural Head
Utah becomes first state to empower AI to bypass doctors and prescribe certain drugs
Radioactive-Americana-Collage-2
The kooky logic behind the raft of spurious cancer claims from Harvard’s T.H. Chan School of Public Health
AI-Force-Uniform-Insignia-Close-Up
Trump wants an AI Force like Space Force, but that could make AI’s risks harder to manage
Screenshot 2026-07-29 at 10.40
The COVID vaccine turbo cancer scare is back. Science still proves it’s wrong.
Screenshot-2026-09-22-at-10.54.12-AM
‘They misunderstand science’: Research attempting to tie autism to changes in the gut microbiome comes under fire
Screenshot-2026-09-28-at-11.26.17-AM
Viewpoint: Wellness movement activists reposition nicotine from a killer addictive drug into a cure-all for brain ills
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
Screenshot-2026-10-07-at-2.00.02-PM
9 wellness myths busted
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.